References
- Thirion P, Holmberg O, Collins C, O'Shea C, Moriarty M, Pomeroy M, et al. Escalated dose for non-small lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother Oncol 2004; 71: 163-6.
- Willner J, Baier K, Caragiani E, Tschammler A, Flentje M. Dose, volume and tumor control predictions in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52: 382-9.
- Baumann M, Herrmann T, Matthiessen, Koch R, Strelocke K, Paul U. CHARTWEL-Bronchus (ARO 97-1): a randomized multicenter trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-call bronchial carcinoma. Strahlenther Onkol 1997; 173: 663-7.
- Ferlay, J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer incidence, Mmortality and prevalence in the European Union 1997. Version 4.0. IARC Cancer Base No. 4. Lyon: IARC; 1999.
- Bray F, Tycynski JE, Parkin DM. Going up or coming down? The changing phases of lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer 2004; 40: 96-125.
- Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005; 61: 318-28.
- Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Klautke G, et al. R. 6-Year Experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable Non-Small Cell Lung Cancer. Strahlenther Onkol 2007; 183: 30-5.
- Sim S, Rosenzweig KE, Schindelheim R, Ng KK, Leibel SA. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001; 51: 660-5.
- Novello S, Le Chevalier T. Use of chemo-radiotherapy in locally advanced non-small cell lung cancer. Eur J Cancer 2002; 38: 292-9.
- Ball D, Matthews J, Worotniuk V, Crennan E. Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer. Int J Radiat Oncol Phys 1993; 25: 599-604.
- Catalano G, Jereczek-Fossa B, De Pas T, Leon ME, Cattani F, Spaggiari L, et al. Three-times daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Strahlenther Onkol 2005; 181: 363-71.
- Rengan R, Rosenzweig KE, Venkatraman E et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004; 60(3): 741-747
- Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall lung carcinoma. Cancer 2005; 103: 2118-27.
- International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda: International Commission on Radiation Units and Measurements; 1993.
- Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis of pneumonitis after 3D treatment for non small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-9.
- Cox JD, Stretz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organisation for Research and Treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
- Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Ass 1958; 53: 457-81.
- Belderbos J, Heemsbergen W, De Jaeger K, Baas P, Lebesque JV. Final results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 126-34.
- Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, et al. Final toxicity results of a radiation-dose escalation study on patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006; 65: 1075-86
- Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323: 940-5.
- Furuse K, Kubota K, Kawahara M, Kodama N, Ogawara M, Akira M, et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non small cell lung cancer. Southern Osaka Lung Cancer Study Group. J Clin Oncol 1995; 13: 869-75.
- Kubota K, Furuse K, Kawahara M, Kodama N, Yamamoto M, Ogawara M, et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol 1994; 12: 1547-52.
- Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-23.
- Barnes E, Murray B, Robinson D, Underwood LJ, Hanson J, Roa WH. Dosimetric evaluation of lung tumour immobilization using breath hold at deep inspiration. Int J Radiat Oncol Biol Phys 2001; 50: 1091-8.
- Hof H, Herfarth KK, Munter M, Essig M, Wannenmacher M, Debus J. The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation. Strahlenther Onkol 2003; 179: 542-7.
- Grills IS, Yan D, Martinez AA, Vicini FA, Wong JW, Kestin LL. Potential for reduced toxicity and does escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Oncol Biol Phys 2003; 57: 875-90.
- Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2004; 73: 285-97.
- De Ruysscher D, Wanders S, Minken A, Lumens A, Schiffelers J, Stultiens C, et al. Effects of radiotherapy planning with dedicated combined PETCT simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 2005; 77: 5-10.